BioSapien’s $5.5 Million Pre-Series A Funding Round

Wilson Sonsini Goodrich & Rosati advised BioSapien on the transaction. BioSapien, an Abu Dhabi-based biotech startup focused on drug delivery for localized cancer treatment, announced the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here